Change of Adviser

RNS Number : 5036U
e-Therapeutics plc
25 June 2009
 



25 June 2009



e-Therapeutics plc

Change of Adviser



The Board of e-Therapeutics plc (the 'Company') (AIM: ETX), the drug discovery and development company, is pleased to announce the appointment of Canaccord Adams Limited as the Nominated Adviser and Broker to the Company with immediate effect.



Enquiries:


e-Therapeutics plc                     O191 233 1317

John Cordiner, Finance Director



Canaccord Adams Limited

Nominated Adviser                    0207 050 6500

Robert Finlay / Henry Fitzgerald-O'Connor




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPBELFLKQBEBBK
UK 100

Latest directors dealings